Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• MDM2 is an E3 ubiquitin ligase inhibiting the p53 tumor suppressor, frequently elevated in human cancers.
• The MDM2 SNP309G polymorphism increases MDM2 levels, reducing p53 activity and impacting tumor development.
• Mdm2^SNP309G/G mice show increased spontaneous tumor formation compared to Mdm2^SNP309T/T mice.

Purpose of the Study:

• To investigate the tissue-specific effects of the MDM2 SNP309G polymorphism on tumor susceptibility.
• To determine how environmental factors interact with MDM2 SNP309G in cancer development.
• To elucidate the molecular mechanisms underlying the tissue-specific regulation of MDM2 by SNP309G.

Main Methods:

• Comparative analysis of tumor development in Mdm2^SNP309G/G and Mdm2^SNP309T/T mice under various conditions (spontaneous, ionizing radiation, UVB, Benzo(a)pyrene).
• Assessment of MDM2 expression levels across different tissues in both mouse genotypes.
• Utilizing the ENCODE ChIP-seq database to identify potential transcriptional regulators of MDM2, followed by experimental validation.

Main Results:

• MDM2 SNP309G exacerbates tumor development with ionizing radiation but protects against skin squamous cell carcinoma induced by UVB or Benzo(a)pyrene.
• Basal MDM2 levels are higher in most tissues of Mdm2^SNP309G/G mice, but paradoxically lower in keratinocytes.
• The transcriptional repressor E2F6 was identified and shown to suppress MDM2 expression specifically in cells with the SNP309G allele.

Conclusions:

• MDM2 SNP309G exhibits significant tissue-specific regulation of MDM2 expression and differential impact on cancer risk.
• The interaction between E2F6 and the MDM2 promoter in the context of SNP309G explains the contrasting susceptibility observed in different tissues.
• Understanding these tissue-specific mechanisms is crucial for targeted cancer prevention and treatment strategies.